Australian private hospital and pathology services provider Healthscope has divested its pathology operations in Singapore, Malaysia and Vietnam to private equity firm TPG Capital Asia.
Local media in Buenos Aires have reported that Swiss Medical Group, an Argentinian private healthcare provider, has invested $80m in a sanatorium for Nordelta.
Grupo Notre Dame Intermédica (GNDI), the private Brazilian insurer headquartered in São Paulo, has agreed to buy 100% of hospital and online database group Grupo Mediplan Sorocaba (GMS).
While the majority of board members of Malaysian-Singaporian healthcare giant IHH voted to support its acquisition of beleaguered Indian hospital group Fortis, there was one notable exception.
India and GCC hospital group Aster DM has revealed revenue and EBITDA growth of 13% and 79%, respectively, in its first annual report since IPOing in Mumbai in February this year. The increase in the proportion of revenues made in India shows the group's pivot towards that market, although it is sticking to the safe haven of larger cities.
Earlier this month, the Ukrainian government set in motion sweeping healthcare reforms that will allow citizens to sign contracts with private providers for the first time. Healthcare Europa speaks to Michael Amsel, CEO of Lissod, a private oncology hospital in the ex-Soviet state, about the investment opportunities this newly-created free market could engender.
Capio's interim report for the year to June 2018 highlighted its strengths and weakness remain divided along geographic lines - but did nothing to dent a share price buoyed by the prospect of a Ramsay takeover.
Global dialysis provider Diaverum saw 76% revenue growth in Romania in 2017 according to the Ministry of Finance. The impressive figures comes as speculation continues over the future of the group's Saudi Arabian contract.
Dr Lal Pathlabs, India's second largest medical laboratory group by revenue, saw revenue growth of 15.7% and EBITDA rise 12.2% in the year to March 31, 2018. The group's CEO says balance sheet cash will primarily be used for M&A going forward.
Healthcare Europa understands that the owners of Barchester Healthcare, the UK's third-largest care home group, have approached JP Morgan to prepare for a sale that could value the business at £2.5bn (€2.8bn).
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
